Aequus Pharmaceuticals Inc.
AQS.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18.80K | 32.20K | 178.70K | 128.90K | 82.80K |
| Total Receivables | 48.30K | 87.60K | 26.70K | 24.00K | 51.60K |
| Inventory | 73.50K | 118.20K | 57.20K | 93.70K | 136.30K |
| Prepaid Expenses | 53.20K | 39.70K | 54.90K | 49.30K | 56.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 33.20K | 32.80K | 33.10K | 34.00K | 33.20K |
| Total Current Assets | 227.00K | 310.50K | 350.60K | 329.90K | 360.20K |
|
|
|||||
| Total Current Assets | 227.00K | 310.50K | 350.60K | 329.90K | 360.20K |
| Net Property, Plant & Equipment | 408.10K | 427.00K | 456.00K | 492.70K | 506.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 635.10K | 737.50K | 806.70K | 822.50K | 866.20K |
|
|
|||||
| Total Accounts Payable | 333.50K | 254.20K | 250.20K | 207.60K | 366.30K |
| Total Accrued Expenses | 65.40K | 58.30K | 21.50K | 31.90K | 129.80K |
| Short-term Debt | 4.39M | 4.06M | 3.70M | 3.31M | 2.49M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 89.50K | 85.70K | 84.00K | 83.40K | 77.80K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 4.88M | 4.46M | 4.05M | 3.63M | 3.07M |
|
|
|||||
| Total Current Liabilities | 4.88M | 4.46M | 4.05M | 3.63M | 3.07M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 4.39M | 4.06M | 3.70M | 3.31M | 2.49M |
| Capital Leases | 363.60K | 381.80K | 408.70K | 441.90K | 452.60K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.24M | 4.84M | 4.46M | 4.07M | 3.52M |
|
|
|||||
| Common Stock & APIC | 17.76M | 17.53M | 17.72M | 18.17M | 17.73M |
| Retained Earnings | -25.64M | -24.86M | -24.63M | -24.75M | -23.63M |
| Treasury Stock & Other | 3.28M | 3.23M | 3.25M | 3.33M | 3.25M |
| Total Common Equity | -4.60M | -4.10M | -3.65M | -3.25M | -2.65M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -4.60M | -4.10M | -3.65M | -3.25M | -2.65M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.60M | -4.10M | -3.65M | -3.25M | -2.65M |
|
|
|||||
